Kanasaki, M., Nagai, T., Kitada, M., Koya, D., & Kanasaki, K. (2011). Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: A blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors. BioMed Central.
Chicago Style CitationKanasaki, Megumi, Takako Nagai, Munehiro Kitada, Daisuke Koya, and Keizo Kanasaki. Elevation of the Antifibrotic Peptide N-acetyl-seryl-aspartyl-lysyl-proline: A Blood Pressure-independent Beneficial Effect of Angiotensin I-converting Enzyme Inhibitors. BioMed Central, 2011.
MLA CitationKanasaki, Megumi, et al. Elevation of the Antifibrotic Peptide N-acetyl-seryl-aspartyl-lysyl-proline: A Blood Pressure-independent Beneficial Effect of Angiotensin I-converting Enzyme Inhibitors. BioMed Central, 2011.